Current concepts on pathogenesis and biology of metastatic osteosarcoma tumors.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Ortopedia Traumatologia Rehabilitacja

• Publication date

  2011-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.5604/15093492.971038PMID 22248458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma.

  2011cited by this paper
• Indentification of cancer stem-like cells in osteosarcoma and their implications in response to chemotherapy

  2010cited by this paper
• Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor

  2010cited by this paper
• Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma

  2010cited by this paper
• Targeting the osteosarcoma cancer stem cell

  2010cited by this paper
• Cancer stem cells: the theory and perspectives in cancer therapy

  2010cited by this paper
• Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell

  2010cited by this paper
• [Angiogenesis and immune suppression: yin and yang of tumor progression?].

  2009cited by this paper
• Bone marrow micrometastases studied by an immunomagnetic isolation procedure in extremity localized non-metastatic osteosarcoma patients.

  2009cited by this paper
• Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2

  2009cited by this paper
• Characterization of stem cell attributes in human osteosarcoma cell lines

  2009cited by this paper
• A complex pattern of chemokine receptor expression is seen in osteosarcoma

  2008cited by this paper
• VEGF blockade decelerates the growth of a murine experimental osteosarcoma.

  2008cited by this paper
• Hypoxia Markers in Human Osteosarcoma: An Exploratory Study

  2008cited by this paper
• RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness

  2007cited by this paper
• Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome.

  2007cited by this paper
• High Level of Ezrin mRNA Expression in an Osteosarcoma Biopsy Sample With Lung Metastasis

  2007cited by this paper
• Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

  2007cited by this paper
• Effects of hypoxia on tumor metabolism

  2007cited by this paper
• CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis

  2006cited by this paper
• Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?

  2006cited by this paper
• Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.

  2006cited by this paper
• Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.

  2005cited by this paper
• Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.

  2005cited by this paper
• Stem-like cells in bone sarcomas: implications for tumorigenesis.

  2005cited by this paper
• Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).

  2005cited by this paper
• Messenger RNA Expression Levels of CXCR4 Correlate with Metastatic Behavior and Outcome in Patients with Osteosarcoma

  2005cited by this paper
• Matrix metalloproteinases participate in osteosarcoma invasion.

  2005cited by this paper
• The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

  2004cited by this paper
• Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcomaFindings in 42 patients followed for 1–16 years

  2004cited by this paper
• Prognostic relevance of increased angiogenesis in osteosarcoma.

  2004cited by this paper
• Evaluation of P‐glycoprotein, HER‐2/ErbB‐2, p53, and Bcl‐2 in primary tumor and metachronous lung metastases in patients with high‐grade osteosarcoma

  2004cited by this paper
• The association of P‐glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma

  2003cited by this paper
• Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities.

  2003cited by this paper
• Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.

  2003cited by this paper
• The role of the CD44/ezrin complex in cancer metastasis.

  2003cited by this paper
• Lack of Prognostic Significance of Intratumoral Angiogenesis in Nonmetastatic Osteosarcoma

  2001cited by this paper
• Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.

  2000cited by this paper
• P‐glycoprotein expression in osteosarcoma: A basis for risk‐adapted adjuvant chemotherapy

  1999cited by this paper
• Oncogenic alterations of metabolism.

  1999cited by this paper
• The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells

  1999cited by this paper
• Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma.

  1999cited by this paper
• [Correlation of tumor microvesseldensity with prognosis in osteogenic sarcoma].

  1997cited by this paper
• Neoplastic Diseases: A Treatise on Tumours

  1928cited by this paper
• THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.

  1889cited by this paper

• The other side of the coin: protein deubiquitination by Ubiquitin-Specific Protease 1 in cancer progression and therapy.

  2025cites this paper
• CDK12 is a promising therapeutic target for the transcription cycle and DNA damage response in metastatic osteosarcoma.

  2024cites this paper
• MicroRNAs as the pivotal regulators of cisplatin resistance in osteosarcoma.

  2023cites this paper
• Vascular Niche Facilitates Acquired Drug Resistance to c-Met Inhibitor in Originally Sensitive Osteosarcoma Cells

  2022cites this paper
• Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS in vitro by targeting RUNX2

  2021cites this paper
• MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A

  2021cites this paper
• Inhibition of ATR-Chk1 signaling blocks DNA double-strand-break repair and induces cytoplasmic vacuolization in metastatic osteosarcoma

  2020cites this paper
• Primary osteosarcoma in elderly patients: A report of three cases

  2019cites this paper
• MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway

  2019cites this paper
• MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway

  2019cites this paper
• Clinical case report of patients with osteosarcoma and anticancer benefit of calycosin against human osteosarcoma cells

  2019influential citation
• miR-29 promotes osteosarcoma cell proliferation and migration by targeting PTEN

  2018cites this paper
• MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma.

  2018cites this paper
• MicroRNA-520d-3p inhibits osteosarcoma progression by degradation of Akt1.

  2018cites this paper
• miR-18a-5p promotes cell invasion and migration of osteosarcoma by directly targeting IRF2

  2018cites this paper
• Rhotekin 2 silencing inhibits proliferation and induces apoptosis in human osteosarcoma cells

  2018cites this paper
• miR‑23b‑3p promotes the apoptosis and inhibits the proliferation and invasion of osteosarcoma cells by targeting SIX1.

  2018cites this paper
• MicroRNA-504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53

  2018cites this paper
• MicroRNA ‐ 129 ‐ 5 p suppresses cell proliferation , migration and invasion via targeting ROCK 1 in osteosarcoma

  2018cites this paper
• MicroRNA ‐ 302 a suppresses cell proliferation , migration and invasion in osteosarcoma by targeting ADAM 9

  2017cites this paper
• Matrix metalloproteinase 9 expression and survival of patients with osteosarcoma: a meta‐analysis

  2017cites this paper
• PAK5 overexpression is associated with lung metastasis in osteosarcoma

  2017cites this paper
• Downregulation of 14-3-3β inhibits proliferation and migration in osteosarcoma cells.

  2017cites this paper
• Downregulation of NKD 1 in human osteosarcoma and its clinical significance

  2017cites this paper
• MicroRNA‑302a suppresses cell proliferation, migration and invasion in osteosarcoma by targeting ADAM9.

  2017cites this paper
• Increased Six1 expression is associated with poor prognosis in patients with osteosarcoma

  2017cites this paper
• Downregulation of NKD1 in human osteosarcoma and its clinical significance.

  2017cites this paper
• Osteosarcoma in the coracoid process that mimicked an osteochondroma

  2017cites this paper
• E2F1 silencing inhibits migration and invasion of osteosarcoma cells via regulating DDR1 expression

  2017cites this paper
• MicroRNA-203 inhibits proliferation and invasion, and promotes apoptosis of osteosarcoma cells by targeting Runt-related transcription factor 2.

  2017cites this paper
• Gene silencing of USP 1 by lentivirus effectively inhibits proliferation and invasion of human osteosarcoma cells

  2016cites this paper
• MicroRNA-638 inhibits cell proliferation by targeting suppress PIM1 expression in human osteosarcoma

  2016cites this paper
• Celastrol negatively regulates cell invasion and migration ability of human osteosarcoma via downregulation of the PI3K/Akt/NF-κB signaling pathway in vitro.

  2016cites this paper
• Gene silencing of USP1 by lentivirus effectively inhibits proliferation and invasion of human osteosarcoma cells.

  2016cites this paper
• Activin A regulates proliferation, invasion and migration in osteosarcoma cells.

  2015cites this paper
• Polo‑like kinase 3 inhibits osteosarcoma cell proliferation and tumorigenesis via cooperative interaction with p21.

  2015cites this paper
• MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN.

  2015cites this paper
• Upregulation of micro-ribonucleic acid-128 cooperating with downregulation of PTEN confers metastatic potential and unfavorable prognosis in patients with primary osteosarcoma

  2014cites this paper
• Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.

  2014cites this paper
• p21-activated kinase 7 is an oncogene in human osteosarcoma

  2014cites this paper
• Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma

  2014cites this paper
• Upregulation of micro-ribonucleic acid-128 cooperating with downregulation of PTen confers metastatic potential and unfavorable prognosis in patients with primary osteosarcoma

  2014cites this paper
• Inhibition of Six1 promotes apoptosis, suppresses proliferation, and migration of osteosarcoma cells

  2014cites this paper
• Upregulation of micro-ribonucleic acid-128 cooperating with downregulation of PTen confers metastatic potential and unfavorable prognosis in patients with primary osteosarcoma

  2014cites this paper
• Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis

  2013cites this paper
• Effects of combined c-myc and Bmi-1 siRNAs on the growth and chemosensitivity of MG-63 osteosarcoma cells.

  2013cites this paper
• Erratum to: MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell

  2013cites this paper
• MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell

  2013cites this paper
• Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis

  2013cites this paper
• Enhanced chemosensitivity by simultaneously inhibiting cell cycle progression and promoting apoptosis of drug-resistant osteosarcoma MG63/DXR cells by targeting Cyclin D1 and Bcl-2

  2012cites this paper
• Polo ‐ like kinase 3 inhibits osteosarcoma cell proliferation and tumorigenesis via cooperative interaction with p 21

  year unknowncites this paper
• Oncotargets and Therapy Dovepress Prognostic Implications of Kindlin Proteins in Human Osteosarcoma

  year unknowncites this paper